LV Cheng-fei, SUN Qiang, WANG Li-xia, CHEN Ming-ting, LI Ren-zhong, RUAN Yun-zhou, ZHAO Jin, CHEN Cheng, SU Wei. Case finding of multidrug-resistant tuberculosis through PPM-DOTS in 4 sites in China[J]. Chinese Journal of Antituberculosis, 2013, 35(12): 955-959.
[1]World Health Organization. Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015: WHO progress report 2011 (WHO/HTM/TB/2011.3). Geneva: World Health Organization, 2011.[2]World Health Organization. Global tuberculosis control: short update to 2009 report. Geneva: World Health Organization, 2009.[3]中华人民共和国卫生部. 全国结核病耐药性基线调查报告(2007—2008年).北京:人民卫生出版社, 2009:30.[4]World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis——2011 update?(WHO/HTM/TB/2011.6). Geneva: World Health Organization, 2011.[5]弭凤玲, 王黎霞,李亮,等. 中国全球基金耐多药结核病项目阶段性实施结果分析. 中国防痨杂志, 2010,32(11): 700-704.[6]World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis(WHO/HTM/TB.2009, 422). 4th ed. Geneva: World Health Organization, 2009.[7]World Health Organization. The global plan to stop TB, 2006—2015(WHO/HTM/STB.2006.35). Geneva: World Health Organization, 2006.[8]徐彩红,李仁忠,赵津,等. 耐多药肺结核患者发现情况分析. 现代预防医学, 2011,38(17):3553-3555.[9]Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet,2010, 375(9728):1830-1843.[10]黄飞,王黎霞,成诗明,等.医防合作对提高肺结核患者发现的影响.中国防痨杂志, 2010, 32(7):361-365.